Michael Singer of Cartesian (NASDAQ: RNAC) reports new options and RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cartesian Therapeutics director Michael Singer reported new equity awards from the company, including 7,800 stock options and 2,600 restricted stock units granted on January 2, 2026. The stock options give him the right to buy 7,800 shares of common stock at $6.76 per share, become exercisable on January 2, 2027, and expire on January 1, 2036. The restricted stock units represent contingent rights to receive 2,600 shares of common stock that will vest in full on January 2, 2027. Following these awards, he directly holds 56,133 common shares and has additional indirect holdings through several trusts, his spouse, and custodial accounts for his children.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Singer Michael
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 7,800 | $0.00 | -- |
| Grant/Award | Common Stock | 2,600 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 7,800 shares (Direct);
Common Stock — 56,133 shares (Direct);
Common Stock — 383,796 shares (Indirect, by trust)
Footnotes (1)
- Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2027. Shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of the trust. Shares are held in a trust for which the reporting person is a beneficiary. The reporting person is a trustee of the trust. Shares are held in a trust for which the reporting person is a beneficiary. The reporting person's spouse is a trustee of the trust. Shares are held by the reporting person's spouse. The shares are held for LS, the child of the reporting person, through a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA") for which the reporting person serves as custodian. The shares are held for SS, the child of the reporting person, through a custodial account established pursuant to the UTMA for which the reporting person serves as custodian.
FAQ
What insider transactions did Cartesian Therapeutics (RNAC) director Michael Singer report?
On January 2, 2026, director Michael Singer reported an award of 7,800 stock options and 2,600 restricted stock units related to Cartesian Therapeutics common stock.
What are the terms of Michael Singer's new stock options at Cartesian Therapeutics (RNAC)?
The 7,800 stock options have an exercise price of $6.76 per share, become exercisable on January 2, 2027, and expire on January 1, 2036.
How do Michael Singer’s 2,600 restricted stock units at RNAC vest?
Each restricted stock unit gives a contingent right to receive one share of common stock, with all 2,600 units vesting in full on January 2, 2027.
What indirect holdings in Cartesian Therapeutics (RNAC) are associated with Michael Singer?
Indirect holdings include shares held by multiple trusts, by his spouse, and through custodial accounts for his children established under the UTMA.
Did Michael Singer pay cash for the reported RNAC equity awards?
The Form 4 shows the 2,600 common-stock-linked units and 7,800 stock options with a reported transaction price of $0.00 for the awards themselves.
Cartesian